Purtscher-like features in new-onset diabetic retinopathy

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Agrawal A, McKibbin M (2007) Purtscher’s retinopathy: epidemiology, clinical features and outcome. Br J Ophthalmol 91(11):1456–1459. https://doi.org/10.1136/bjo.2007.117408

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Miguel AI, Henriques F, Azevedo LF, Loureiro AJ, Maberley DA (2013) Systematic review of Purtscher’s and Purtscher-like retinopathies. Eye (Lond) 27(1):1–13. https://doi.org/10.1038/eye.2012.222

    CAS  Article  Google Scholar 

  3. 3.

    Ong T, Nolan W, Jagger J (2005) Purtscher-like retinopathy as an initial presentation of thrombotic thrombocytopenic purpura: a case report. Eye (Lond) 19(3):359–361. https://doi.org/10.1038/sj.eye.6701491

    CAS  Article  Google Scholar 

  4. 4.

    Schroder S, Palinski W, Schmid-Schonbein GW (1991) Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 139(1):81–100

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Kuroda M, Nishida A, Kikuchi M, Kurimoto Y (2013) Purtscher’s retinopathy followed by neovascular glaucoma. Clin Ophthalmol 7:2235–2237. https://doi.org/10.2147/OPTH.S54231

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Maria Vittoria Cicinelli.

Ethics declarations

Conflict of interest

MVC, MB, VS, RL declare that they have no conflict of interest. FB consultant for: Alcon (Fort Worth, Texas, USA), Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc (Irvine, California, USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering-Pharma (Berlin, Germany), Bausch And Lomb (Rochester, New York, USA), Genentech (San Francisco, California, USA), Hoffmann-La-Roche (Basel, Switzerland), NovagaliPharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee, Belgium), Zeiss (Dublin, USA).

Ethical approval

The study adhered to the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Managed by Giuseppe Querques.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Battista, M., Cicinelli, M.V., Starace, V. et al. Purtscher-like features in new-onset diabetic retinopathy. Acta Diabetol 57, 377–379 (2020). https://doi.org/10.1007/s00592-019-01401-x

Download citation